Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EBIT Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 41.78-15.6018.7817.2359.00

What is the latest EBIT Growth ratio of MANKIND PHARMA ?

The latest EBIT Growth ratio of MANKIND PHARMA is 41.78 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202441.78
Mar2023-15.60
Mar202218.78
Mar202117.23
Mar202059.00

How is EBIT Growth of MANKIND PHARMA Trending?

Years EBIT Growth % Change
Mar2024 41.78
Positive
Mar2023 -15.6
Negative
Mar2022 18.78
9.00
Mar2021 17.23
-70.80
Mar2020 59 -

Other Financial Ratios of MANKIND PHARMA


Compare EBIT Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹100,173.1 Cr -1.4% 4.5% 4.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,706.0 Cr 2.3% 11.7% 5.1% Stock Analytics
DIVIS LABORATORIES ₹152,946.0 Cr -1.6% 4% 58.7% Stock Analytics
CIPLA ₹120,751.0 Cr 0.8% 6.2% -2.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,988.0 Cr 0.7% 9.8% 19.8% Stock Analytics
DR REDDYS LABORATORIES ₹96,066.7 Cr -1% 2.8% -8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.4%

4.5%

4.7%

SENSEX

-1.3%

4.2%

3.6%


You may also like the below Video Courses